Literature DB >> 6330076

Effects of phosphorylation of avian retrovirus nucleocapsid protein pp12 on binding of viral RNA.

J Leis, S Johnson, L S Collins, J A Traugh.   

Abstract

The major nucleocapsid protein of avian retroviruses, pp12, preferentially binds to the single-stranded regions of 60 S viral RNA with a apparent binding constant (Kapp) of 1.2 X 10(11) M-1. If the phosphate associated with serine residues of pp12 is hydrolyzed by either alkali treatment or with partially purified phosphoprotein phosphatase activities isolated from virions, the Kapp for binding to 60 S RNA decreases 100-fold. The high affinity binding of pp12 to viral RNA can be restored by phosphorylation of the protein with a protein kinase, protease-activated kinase I. The same serine residues phosphorylated in vivo are phosphorylated by protease kinase I in vitro. These residues have been identified as serine residues 40 and either 76 or 77. The protein purified from virions is phosphorylated primarily at serine residue 40 (greater than 90%). This suggests that phosphoserine residue 40 is responsible for modulating the binding of the protein to RNA. Thus, the phosphorylation state of pp12 can be reversibly altered in vitro resulting in the interconversion of the protein between a state of high and low affinity for single-stranded viral RNA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330076

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription.

Authors:  A Aiyar; D Cobrinik; Z Ge; H J Kung; J Leis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 2.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

3.  In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.

Authors:  S Beushausen; S Narindrasorasak; B D Sanwal; S Dales
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Role of the gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA.

Authors:  S Oertle; P F Spahr
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging.

Authors:  C Méric; P F Spahr
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain.

Authors:  F Alexander; J Leis; D A Soltis; R M Crowl; W Danho; M S Poonian; Y C Pan; A M Skalka
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

7.  Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase.

Authors:  R B Pepinsky; I A Papayannopoulos; S Campbell; V M Vogt
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

8.  Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart.

Authors:  R Hromas; E A Williamson; S Fnu; Y-J Lee; S-J Park; B D Beck; J-S You; A Leitao; A Laitao; J A Nickoloff; S-H Lee
Journal:  Oncogene       Date:  2012-01-09       Impact factor: 9.867

9.  Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5'-terminal genomic RNA fragment.

Authors:  I Katoh; H Kyushiki; Y Sakamoto; Y Ikawa; Y Yoshinaka
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses.

Authors:  I Katoh; T Yasunaga; Y Yoshinaka
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.